Furthermore, in patients with breast cancer, a limited bioinformatics analysis shows that patient outcome (metastases-free survival) is associated with an inverse pattern of metabolism-related (LDH-A and HIF-1α) and immune-associated (CD3E and CD8A, CD4) gene expression. This evidence concerns the gene CD3E and breast carcinoma.